Trials / Recruiting
RecruitingNCT06480916
Study of the Value of Maternal-fetal Transfers and Their Complexity of Their Implementation
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Centre Hospitalier Régional Metz-Thionville · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
It is an observational, descriptive, prospective, multicenter study of 8 maternity units in Lorraine and Champagne-Ardenne, aimed at comparing the percentage of "avoidable" maternal-fetal transfers (MFTs), defined as transfers in which the delivery finally meets the acceptance criteria of the sending maternity unit, according to the obstetrical indications for these MFTs.
Detailed description
Over the past year, an audit carried out on the Mercy maternity unit, covering 130 transfers to the Nancy regional maternity hospital, showed that patients transferred for threat of premature delivery (MAP) with a cervix \> 15 mm do not give birth at the receiving maternity unit, but return home after 48 hours' hospitalization. When maternal-fetal transfer (MFT) is requested, numerous calls are made to private ambulance services, and in the end, many emergency rapid response units (SMUR) are called out, requiring a major human, logistical and time investment for a questionable benefit to the patient. Tensions in terms of logistics (lack of ambulance, SMUR) and human resources (lack of personnel) can, conversely, compromise good care of the parturient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Maternal-fetal transfers | Prospective and consecutive inclusion of all maternal-fetal transfers during the study period. The teams at the sending and receiving maternity units will complete study-related questionnaires to describe the conditions of the transfer and the outcome of the pregnancy. The study in no way alters the way parturients are cared for. |
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2025-04-01
- Completion
- 2025-04-01
- First posted
- 2024-06-28
- Last updated
- 2024-06-28
Locations
8 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06480916. Inclusion in this directory is not an endorsement.